FW: INCIDENCE OF CARDIOVASCULAR ADVERSE EVENTS SIMILAR AMONG PATIENTS TREATED WITH CELECOXIB, NONSTEROIDAL ANTI-INFLAMMATORIES, OR PLACEBO

[Guest guest]

INCIDENCE OF CARDIOVASCULAR ADVERSE EVENTS SIMILAR AMONG PATIENTS TREATED

WITH CELECOXIB, NONSTEROIDAL ANTI-INFLAMMATORIES, OR PLACEBO

In arthritis patients treated with the cyclooxygenase-2 (COX-2) inhibitor

celecoxib, no significant increase in cardiovascular events occurs compared

to patients treated with nonselective nonsteroidal anti-inflammatory drugs

(NSAIDs) or placebo, say researchers.

Doctor¹s Guide, Sep 10 (free registration required)

http://www.docguide.com/news/content.nsf/news/8525697700573E1885256D83002C14

29?OpenDocument & id=08133D380D89E7AE85256D3B00159F3B & c=Arthritis%20Other & coun

t=10

------ End of Forwarded Message